Atypical hyperplasia, proliferative fibrocystic change, and exogenous hormone use

Surgery

Volumn 130, Issue 4, 2001, Pages 732-737

  Zera, Richard T ^a   Danielson, Daren ^a   Van Camp, Joan M ^a   Schmidt Steinbrunn, Barbara ^a   Hong, Jennifer ^a   McCoy, Mathew ^a   Anderson, William R ^a   Linzie, Bradley M ^a   Rodriguez, Jorge L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST HYPERPLASIA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROCYSTIC BREAST DISEASE; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL;

EID: 0034788389     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2001.117373     Document Type: Article

References (18)

1. Hormone replacement therapy and the risk of breast cancer: Results from epidemiologic studies
2. Breast cancer and hormone replacement therapy: Collaborative re-analysis of data from 51 epidemiological studies of 52, 705 women with breast cancer and 108, 411 women without breast cancer
3. Menopausal hormone replacement therapy and breast cancer: A meta-analysis
4. Estrogen replacement therapy and breast cancer
5. A prospective study of benign breast disease and the risk of breast cancer
6. Influence of exogenous estrogens, proliferative breast disease and other variables on breast cancer risk
7. Benign breast changes and the risk for subsequent breast cancer
8. Benign breast disease and breast carcinoma
9. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast
10. Benign, high risk, and premalignant lesions of the breast
11. Estrogen replacement therapy and fibrocystic breast disease in post menopausal women
12. Conjugated estrogens and fibrocystic breast disease
13. Histologic and mammographic specificity of risk factors for benign breast disease
14. Risk factors for benign breast disease
15. Estrogen replacement therapy in women with a history of proliferative breast disease
16. Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia
17. Direct action of estrogen on sequence of progression of human preneoplastic breast disease
18. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study